Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Janssen LP

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder

Phase 3

Completed

Conditions: Schizophrenia
Psychotic Disorders

First Posted Date: 2005-10-12

Last Posted Date: 2011-05-17

Lead Sponsor: Janssen, LP

Target Recruit Count: 86

Registration Number: NCT00236353

A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder

Phase 4

Completed

Conditions: Schizophrenia
Diabetes Mellitus

Interventions: Drug: Risperidone
Drug: Olanzapine

First Posted Date: 2005-10-12

Last Posted Date: 2011-05-17

Lead Sponsor: Janssen, LP

Target Recruit Count: 59

Registration Number: NCT00236379

A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis

Phase 3

Completed

Conditions: HIV Infections
Histoplasmosis
Blastomycosis

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Janssen, LP

Target Recruit Count: 60

Registration Number: NCT00002159

Locations: 🇺🇸
UAB Station / Infectious Division, Birmingham, Alabama, United States
🇺🇸
Univ of Arkansas for Med Sciences, Little Rock, Arkansas, United States
🇺🇸
Division of Infectious Diseases, Atlanta, Georgia, United States

and more 6 locations

Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)

Not Applicable

Completed

Conditions: Cryptosporidiosis
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Janssen, LP

Target Recruit Count: 60

Registration Number: NCT00002027

Locations: 🇺🇸
Dr Douglas Dieterich, New York, New York, United States
🇺🇸
Cornell Univ Med Ctr, New York, New York, United States
🇺🇸
Saint Luke's - Roosevelt Hosp Ctr, New York, New York, United States

A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole

Not Applicable

Completed

Conditions: Candidiasis, Oral
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Janssen, LP

Registration Number: NCT00002341

Locations: 🇺🇸
Buckley Braffman Stern Med Associates, Philadelphia, Pennsylvania, United States

Study of Itraconazole in Patients With Advanced HIV Infection

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Janssen, LP

Target Recruit Count: 36

Registration Number: NCT00002370

Locations: 🇺🇸
Erie County Med Ctr / Pharmacy D, Buffalo, New York, United States

A Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected Patients

Not Applicable

Completed

Conditions: HIV Infections
Histoplasmosis

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Janssen, LP

Registration Number: NCT00002438

Locations: 🇺🇸
Infectious Diseases Research Clinic / Indiana Univ Hosp, Indianapolis, Indiana, United States
🇺🇸
Infectious Diseases of Indianapolis, Indianapolis, Indiana, United States
🇺🇸
Univ of Missouri at Kansas City School of Medicine, Kansas City, Missouri, United States

and more 4 locations

A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS

Not Applicable

Completed

Conditions: Cryptosporidiosis
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Janssen, LP

Registration Number: NCT00002278

Locations: 🇺🇸
Bellevue Hosp / New York Univ Med Ctr, New York, New York, United States
🇺🇸
Cornell Univ Med Ctr, New York, New York, United States
🇺🇸
Saint Luke's - Roosevelt Hosp Ctr, New York, New York, United States

An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.

Not Applicable

Completed

Conditions: Candidiasis, Oral
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Janssen, LP

Registration Number: NCT00002133

Locations: 🇺🇸
Univ of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Univ of Arkansas for Med Sciences, Little Rock, Arkansas, United States
🇺🇸
East Bay AIDS Ctr, Berkeley, California, United States

and more 15 locations

Evaluation of Galantamine in the Treatment of Alzheimer's Disease

Phase 3

Completed

Conditions: Alzheimer Disease

First Posted Date: 1999-11-01

Last Posted Date: 2005-06-24

Lead Sponsor: Janssen, LP

Registration Number: NCT00000172

Locations: 🇺🇸
University of Alabama, Birmingham, Birmingham, Alabama, United States
🇺🇸
James L. Frey, M.D., Ltd., Scottsdale, Arizona, United States
🇺🇸
East Bay Neurology, Berkeley, California, United States

and more 52 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy